Abstract
Renal transplantation is accepted as the treatment of choice for children with end-stage renal disease (ESRD). Over the past decade, improved short-term graft survival has been observed in children and adults with kidney transplantation; however, long-term survival has not improved. The causes of renal allograft dysfunction vary with the time after transplantation. Slowly progressive renal disease that occurs over a period of years after renal transplantation most commonly results from chronic allograft injury, calcineurin inhibitor toxicity, hypertensive nephrosclerosis, viral infections, and recurrent or de novo renal disease. Preventable causes of late allograft failure are important to identify in order to improve the long-term successful outcome of allograft survival. Re-transplantation in the pediatric population is likely to be common into adulthood. Primary reasons for late allograft failure will impact the success of re-transplantation.
References
Ahmad N, Ahmed K, Mamode N (2009) Does nephrectomy of failed allograft influence graft survival after re-transplantation? Nephrol Dial Transplant 24:639–642
Akoh JA (2011) Transplant nephrectomy. World J Transplant 1(1):4–12
Artero ML, Sharma R, Savin VJ et al (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J K Dis 23(4):574–581
Baluarte HJ, Palmer JA, Lopez S et al (2011) Recurrence of Focal Segmental Glomerulosclerosis (FSGS) in children after renal transplantation. Pediatr Transplant 15(Suppl 1):25
Bennet WM (2005) The failed renal transplant: in or out? Semin Dial 18:18–189
Bergstralh EJ, Monico CG, Lieske JC et al (2010) Transplantation outcomes in primary hyperoxaluria. Am J Transplant 10(11):2493–2501
Bomback AS, Smith RJ, Barile GR et al (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7(5):748–756
Canaud G, Zuber J, Sberro R et al (2009) Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 9(5):1081–1086
Chaudhuri A, Ozawa M, Everly MJ et al (2013) The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol 24(4):655–664
Cheong HI, Han HW, Park HW et al (2000) Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 15(1):78–81
Cochat P, Fargue S, Mestrallet G et al (2009) Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 24(11):2097–2108
Cornell LD, Colvin RB (2005) Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 14(3):229–234
Dall’Amico R, Ghiggeri G, Carraro M et al (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34(6):1048–1055
Dantal J, Bigot E, Bogers W et al (1994) Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330(1):7–14
Dharnidharka VR, Cherikh WS, Neff R et al (2010) Re-transplantation after BK virus nephropathy in prior kidney transplant: an OPTN data base analysis. Am J Transplant 2010(10):1312–1315
Dharnidharka VR, Fiorina P, Harmon WE (2014) Kidney transplantation in children. N Engl J Med 371(6):549–558
Farney AC, Matas AJ, Noreen HJ et al (1996) Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival? Clin Transplant 10(2):147–156
Fine RN (1985) Renal transplantation for children – the only realistic choice. Kidney Int Suppl 17:S15–S17
Fine RN (2007) Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22:496–502
Fuentes GM, Mesenguer CG, Carrion AP (2010) Long term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol 25(3):529–534
Geetha D, Sozio SM, Ghanta M et al (2011) Results of repeat renal transplantation after graft loss from BK nephropathy. Transplantation 92(7):781–786
Genevri F, Pastorino N, de Santis R et al (2003) Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcomes without allograft nephropathy. Am J Kidney Dis 42(4):821–825
Goldfarb-Rumyantzev A, Hurdle J, Baird B et al (2006) The role of pre-emptive re-transplant in graft and recipient outcome. Nephrol Dial Transplant 21:1355–1364
Gregoor PJ, Kramer P, Weimar W et al (1997) Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression. Transplantation 63(10):1528–1530
Groothoff JW, Cransberg K, Offringa M et al (2004) Long term follow up of renal transplantation in children: a Dutch cohort study. Transplantation 78(3):453–460
Guyot C, Nguyen JM, Cochat P et al (1996) Risk factors for chronic rejection in pediatric renal allograft recipients. Pediatr Nephrol 10(6):723–727
Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14(2):272–283
Hariharan S, Adams MB, Brennan DC et al (1999) Recurrent and de novo glomerular disease after renal transplantation; a report from Renal Allograft Disease Registry (RADR). Transplantation 68(5):635–641
Hickson LJ, Gera M, Amer H et al (2009) Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 87(8):1232–1239
Icard P, Hooper BR, Gipson DS et al (2010) Cognitive improvement in children with CKD after transplant. Pediatr Transplant 14(14):887–890
Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10(6):651–657
Kotanko P, Pusey CD, Levy JB (1997) Recurrent glomerulonephritis following renal transplantation. Transplantation 63(8):1045–1052
Loirat C, Niaudet P (2003) The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18(11):1095–1101
McDonald SP, Craig JC (2004) Long term survival of children with end stage renal disease. N Engl J Med 350(26):2654–2662
Melk A, Gourishankar S, Halloran PF (2002) Long-term effects of nonimmune tissue injury in renal transplantation. Curr Opin Organ Transplant 7:171–177
Miner JH, Baigent C, Flinter F et al (2014) The 2014 international workshop on Alport syndrome. Kidney Int 86(4):679–684
Monteverde ML, Chaparro A, Goldberg J et al (2015) Donor specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: prevalence, histological correlations, and impact on patient and graft survival. Pediatr Transplant 9:684–690
Moroni G, Longhi S, Quaglini S et al (2013) The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant 28(5):1305–1314
Nankivell BJ, Kuypers DR (2011) Diagnosis and prevention of chronic kidney allograft loss. Lancet 378(9800):1428–1437
Nankivell BJ, Borrows RJ, Fung CL et al (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326–2333
NAPRTCS (2014) Annual transplant report. Available at http://www.naprtcs.org. Accessed 29 Oct 2015
OPTN/SRTR (2012) Annual data report. http://www.ustransplant.org. Accessed 1 Sept 2015
Pape L, Becker JV, Immenscherh S et al (2015) Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol 30:417–424
Perseghin P, Capra M, Baldini V et al (2001) Bradykinin production during plasmapheresis procedures. Vox Sang 81(1):24–28
Peruzzi L, Amore A, Copo R (2014) Challenges in pediatric renal transplantation. World J Transplant 4(4):222–228
Pickering MC, D’Agati VD, Nester CM et al (2013) C3 glomerulopathy: consensus report. Kidney Int 84(6):1079–1089
Pradhan M, Petro J, Palmer J et al (2003) Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 18:934–938
Saland J (2014) Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab? Pediatr Nephrol 29(3):329–332
Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334(14):878–883
Scheinman JI (2010) Liver transplantation in oxalosis prior to advanced chronic kidney disease. Pediatr Nephrol 25(11):2217–2222
Solez K, Colvin RB, Racusen LC et al (2007) Banff ’05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 7(3):518–526
Spinale HJM, Mariani LH, Kapoor S et al (2015) A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int 87(3):564–574
Surga N, Viart L, Wetzstein M (2013) Impact of renal graft nephrectomy on second transplant survival. Int Urol Nephrol 45(1):87–92
Tait BD, Susal C, Gebel HM et al (2013) Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 15(95):19–47
Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2(12 Suppl):S258–S263
Tittlebach-Helmrich D, Pisarski P, Offermann G et al (2014) Impact of transplant nephrectomy on peak PRA levels and outcome after kidney re-transplantation. World J Transplant 4(2):141–147
Trachtman R, Sran SS, Trachtman H (2015) Recurrent focal segmental glomerulosclerosis after kidney transplantation. Pediatr Nephrol 30(10):1793–1802
Van Amstel SP, Vogelzang J, Starnik M et al (2015) Long-term risk of cancer in survivors of pediatric ESRD. Clin J Am Soc Nephrol 10:1–7
Vincenti F, Ghiggeri GM (2005) New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 5(6):1179–1185
Wei C, El Hindi S, Li J, Fornoni A et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952–960
Yu CC, Fornoni A, Weins A et al (2013) Abatacept in B7-1 positive proteinuric kidney disease. N Engl J Med 370(13):1263–1266
Zuber J, Le Quintrec M, Krid S et al (2012) Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant 12(12):3337–3354
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Baluarte, H.J., Palmer, J.A. (2016). Late Allograft Loss of Function: Recurrence of Disease, Chronic Allograft Injury (Immune and Nonimmune Mediated), and Re-transplantation. In: Dunn, S., Horslen, S. (eds) Solid Organ Transplantation in Infants and Children. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-08049-9_34-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-08049-9_34-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-08049-9
eBook Packages: Springer Reference MedicineReference Module Medicine